Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
David A. Janowick
Observed names:
D. JANOWICK,
D. Janowick,
David A Janowick,
David Janowick
Institution:
Takeda Oncology (United States)
Observed institutions:
Abbott (United States),
Bridge Pharma (United States),
Takeda Oncology (United States),
Hoechst Marion Roussel (United States),
The Ohio State University
OpenAlex ID:
A5045496263
Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel In Vivo Pharmacodynamic Assays
2011
·
Mark G. Manfredi
, Jeffrey A. Ecsedy
, et al.
·
Clinical Cancer Research
·
334
NMR Structure and Mutagenesis of the N-Terminal Dbl Homology Domain of the Nucleotide Exchange Factor Trio
1998
·
Xiaohong Liu
, Hong Wang
, et al.
·
Cell
·
192
PDF
Novel Inhibitors of Erm Methyltransferases from NMR and Parallel Synthesis
1999
·
Philip J. Hajduk
, Jürgen Dinges
, et al.
·
Journal of Medicinal Chemistry
·
131
MLN8054 and Alisertib (MLN8237): Discovery of Selective Oral Aurora A Inhibitors
2015
·
Todd B. Sells
, Ryan Chau
, et al.
·
ACS Medicinal Chemistry Letters
·
124
PDF
Selective Protein Tyrosine Phosphatase 1B Inhibitors: Targeting the Second Phosphotyrosine Binding Site with Non-Carboxylic Acid-Containing Ligands
2003
·
Gang Liu
, Zhili Xin
, et al.
·
Journal of Medicinal Chemistry
·
114
Discovery and Structure−Activity Relationship of Oxalylarylaminobenzoic Acids as Inhibitors of Protein Tyrosine Phosphatase 1B
2003
·
Gang Liu
, Bruce G. Szczepankiewicz
, et al.
·
Journal of Medicinal Chemistry
·
67
Discovery of a Potent and Orally Bioavailable Benzolactam-Derived Inhibitor of Polo-Like Kinase 1 (MLN0905)
2011
·
Matthew O. Duffey
, Tricia J. Vos
, et al.
·
Journal of Medicinal Chemistry
·
60
Design, Synthesis, and in Vitro Evaluation of Cyclic Nitrones as Free Radical Traps for the Treatment of Stroke
1996
·
Thomas L. Fevig
, S. Marc Bowen
, et al.
·
Journal of Medicinal Chemistry
·
44
CoMFA, Synthesis, and Pharmacological Evaluation of (E)-3-(2-Carboxy-2-arylvinyl)-4,6-dichloro-1H-indole-2-carboxylic Acids: 3-[2-(3-Aminophenyl)-2-carboxyvinyl]-4,6-dichloro-1H-indole-2-carboxylic Acid, a Potent Selective Glycine-Site NMDA Receptor Antagonist
2005
·
Bruce M. Baron
, Robert J. Cregge
, et al.
·
Journal of Medicinal Chemistry
·
32
MLN8237: an orally active small molecule inhibitor of Aurora A kinase in phase I clinical trials
2008
·
Todd B. Sells
, Jeffrey Ecsedy
, et al.
·
Cancer Research
·
23
A Method for Assigning Phenylalanines in Proteins
1999
·
Hong Wang
, David A. Janowick
, et al.
·
Journal of the American Chemical Society
·
23
Cyclic Nitrone Free Radical Traps: Isolation, Identification, and Synthesis of 3,3-Dimethyl-3,4-dihydroisoquinolin-4-ol N-Oxide, a Metabolite with Reduced Side Effects
1996
·
Craig E. Thomas
, Patrick Bernardelli
, et al.
·
Journal of Medicinal Chemistry
·
19
Beneficial replacement of the P1 phenylalanine side chain in HIV-1 protease inhibitors of the difluorostatone type
1994
·
D. Schirlin
, V. Van Dorsselaer
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
14
Increased antiviral activity of HIV protease inhibitors of the difluorostatone type bearing (R)-valinol derivatives as novel c-termini
1994
·
V. Van Dorsselaer
, D. Schirlin
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
7
Synthesis of (E)-3-(2-carboxy-2-pyridyl-vinyl)-4,6-dichloro-1H-indole-2-carboxylic acids, glycine-site NMDA receptor antagonists, utilizing the Knoevenagel condensation reaction
2001
·
Robert J Cregge
, Robert A Farr
, et al.
·
Tetrahedron Letters
·
6
Non-carboxylic Acid-Containing Inhibitor of PTP1B Targeting the Second Phosphotyrosine Site
2003
·
G. Liu
, Z. Xin
, et al.
·
Worldwide Protein Data Bank
·
1
Supplementary Figure Legends 1-4 from Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel In Vivo Pharmacodynamic Assays
2023
·
Mark G. Manfredi
, Jeffrey A. Ecsedy
, et al.
Supplementary Figure 1 from Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel In Vivo Pharmacodynamic Assays
2023
·
Mark G. Manfredi
, Jeffrey A. Ecsedy
, et al.
Supplementary Figure 4 from Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel In Vivo Pharmacodynamic Assays
2023
·
Mark G. Manfredi
, Jeffrey A. Ecsedy
, et al.
PDF
Supplementary Figure 3 from Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel In Vivo Pharmacodynamic Assays
2023
·
Mark G. Manfredi
, Jeffrey A. Ecsedy
, et al.
Supplementary Figure 2 from Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel In Vivo Pharmacodynamic Assays
2023
·
Mark G. Manfredi
, Jeffrey A. Ecsedy
, et al.
PDF
Data from Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel In Vivo Pharmacodynamic Assays
2023
·
Mark G. Manfredi
, Jeffrey A. Ecsedy
, et al.
Data from Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel In Vivo Pharmacodynamic Assays
2023
·
Mark G. Manfredi
, Jeffrey A. Ecsedy
, et al.
ChemInform Abstract: Synthesis of (E)‐3‐(2‐Carboxy‐2‐pyridyl‐vinyl)‐4,6‐dichloro‐1H‐indole‐2‐carboxylic Acids, Glycine‐Site NMDA Receptor Antagonists, Utilizing the Knoevenagel Condensation Reactions.
2001
·
Robert J. Cregge
, Robert A. Farr
, et al.
·
ChemInform
ChemInform Abstract: Beneficial Replacement of the P1 Phenylalanine Side Chain in HIV‐1 Protease Inhibitors of the Difluorostatone Type.
1994
·
D. SCHIRLIN
, V. VAN DORSSELAER
, et al.
·
ChemInform
Show more works
View as search
Works count:
25
Citation count:
1,191
H-index:
13
I10-index:
13
Year
Topic
Type